TD Cowen analyst Jonna Kim initiated coverage of Hims & Hers with an Outperform rating and $11 price target. Hims & Hers is a leading health and wellness digital platform that connects consumers to healthcare professionals across a variety of specialties, the analyst tells investors in a research note. The firm believes the current stock price does not fully appreciate the company’s growth potential with a $150B total addressable market. It sees a pathway to 20% revenue and high 20% earnings growth over the long term.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on HIMS:
- Hims & Hers down 4% at $8.31 after Strong Sell call from Spruce Point Capital
- Spruce Point calls Hims & Hers a ‘Strong Sell’, sees 25%-40% downside risk
- Spruce Point Capital issues “Strong Sell’ opinion on Hims & Hers
- Fly Insider: Children’s Place, Netflix among notable insider trades this week
- Jefferies has ‘99.9%’ confidence in Q2 revenue beat from Hims & Hers